About Resilience
Resilience is a biomanufacturing company specializing in pharmaceuticals. The team is dedicated to producing complex solutions, including gene therapies, vaccines, and cell therapies. Founded in 2020 by Drew Oetting, Patrick Yang, Ph.D., Sandesh Mahatme, and Rahul Singhvi, Ph.D., the company is headquartered in La Jolla, CA.
Resilience Industries Press Mentions
Stay in the know about the latest news on Resilience Industries
Investors in Resilience Industries
Discover investors in Resilience Industries stock and explore their portfolio companies
Resilience Industries Management
Leadership team at Resilience Industries
Management Team
Syed Husain
Chief Commercial Officer
Elliot Menschik Ph.D
Chief Digital Officer
Spencer Fisk
Chief Technology Officer
Ori Solomon JD
Chief Legal Officer, General Counsel
Duane Avant
Chief Quality Officer
Viet Nguyen
Chief Manufacturing Officer
Rahul Singhvi Ph.D
Co-Founder, Chief Executive Officer & Board Member
Sandesh Mahatme
Co-Founder, President, Chief Financial Officer & Chief Operating Officer
Drew Oetting
Co-Founder & Board Member
Patrick Yang
Co-Founder
Board Members
Scott Gottlieb MD
New Enterprise Associates
Susan Desmond-Hellmann MD
GV
Register To Buy and Sell Shares
For more details on private stock price information, financing and valuation for Resilience, register or login.
- Resilience's current valuation
- Resilience's stock price
- Explore available deals for Resilience and other companies
- Access deal offering documents
- Pre-Ipomarket's exclusive data and insights, including:
- Cap tables showing funding history by Share Class and Liquidity Preferences
- Key Company Highlights
- Detailed Business Model
- Identified Risk Factors
By registering, you agree to StockMe's Terms of Use. Already registered? Log in
Frequently Asked Questions
How to invest in Resilience shares?
Accredited investors can purchase pre-IPO stock in companies like Resilience through platforms like pre-ipomarket. These shares are typically offered by early employees who are seeking liquidity for personal life events, such as buying a home or funding education. Investors can access these opportunities through funds similar to those used by hedge funds for large investors. While private company investments come with risks, they offer the potential for portfolio diversification, access to growth, and high returns. Learn more about our guided investment process.
How to sell Resilience shares?
Shareholders have the option to sell their Resilience stock through pre-ipomarket’s private company marketplace. The platform connects sellers with a large network of accredited investors who are interested in purchasing shares of private companies. Learn more about the streamlined and guided process for shareholders here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on pre-ipomarket. The first is if the company undergoes an exit event, such as an IPO, merger, or acquisition. In such cases, your shares and/or cash will be distributed directly to you. The second option, if eligible, is through an Express Deal. This allows you to sell your allocation of private shares in a specific company to another investor via the pre-ipomarket platform.
Why choose Pre-Ipomarket?
pre-ipomarket has simplified the process of buying and selling shares in private companies. The platform connects investors with shareholders, offering liquidity to early shareholders and providing accredited investors with access to private market opportunities. With low investment minimums and over 42K private placements completed across 450+ companies, pre-ipomarket is a leader in making "Private Markets for the Public."
